Chiropractors in Grafton, ND Accepting Medicare
5 Chiropractors found. Showing 1 - 5
 Blanchards Chiropractic Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 631 W 12th Street, Grafton, ND 58237 Phone: 701-352-1690 Fax: 701-352-2258 |
 Dr. Ashleigh Rose Miller, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 728 Hill Ave, Grafton, ND 58237 Phone: 701-352-0400 Fax: 701-352-0220 |
 Dr. Jonathan Edward Jelinek, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 808 W 12th St, Grafton, ND 58237 Phone: 701-352-0400 Fax: 701-352-0220 |
Dr. Jerry Dean Blanchard, CHIROPRACTOR Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 631 W 12th Street, Grafton, ND 58237 Phone: 701-352-1690 Fax: 701-352-2258 |
Back In Motion Chiropractic Clinic Chiropractor Medicare: Medicare Enrolled Practice Location: 808 W 12th St, Grafton, ND 58237 Phone: 701-352-0400 |
News Archive
New study explores patients' and family members' views on overlapping surgeries
Patients and family members are either neutral or uncomfortable with the idea of "overlapping" or "concurrent" surgery, where the attending surgeon isn't present in the operating room for part of the procedure, according to survey results published in the November 15, 2017 issue of The Journal of Bone & Joint Surgery. The journal is published in partnership with Wolters Kluwer.
Identification of neurotransmitter imbalance in Tourette Syndrome offers new treatment hope
Recent research, published yesterday, has identified a chemical transmitter in the brain that plays a vital role in Tourette Syndrome. This latest finding presents the potential for developing targeted, and therefore more effective, treatments to suppress the distressing symptoms of Tourette Syndrome.
Simple blood test measures the body's immune response to improve ovarian cancer diagnosis
Researchers have developed a simple blood test that measures the body's own immune response to improve diagnosis of ovarian cancer.
Mylan receives FDA approval for Azithromycin tablets
Mylan Laboratories Inc. ( NYSE:MYL ) today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Azithromycin Tablets, 250 mg and 500 mg.
Biodegradable and bioresorbable polymers workshop hosted by Lucideon
Lucideon, the international materials technology company, in conjunction with the University of Cambridge, Granta Design, NC State University and the University of North Carolina, is hosting a 2-day ‘Science for Industry' workshop on Biodegradable and Bioresorbable Polymers (BBPs).
› Verified 4 days ago
Speech-Language Pathologists
Physical Therapists
Occupational Therapists
Chiropractors
Optometrists